Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
Open accessThe DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Abstract
Research elucidating the pathogenesis of systemic lupus erythematosus (SLE) has defined two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic acids and nucleic acid-binding proteins, as fundamental contributors to the disease. On the fertile background of significant genetic risk, a triggering stimulus, perhaps microbial, induces IFN-I, autoantibody production or most likely both. When innate and adaptive immune system cells are engaged and collaborate in the autoimmune response, clinical SLE can develop. This review describes recent data from genetic analyses of patients with SLE, along with current studies of innate and adaptive immune function that contribute to sustained IFN-I pathway activation, immune activation and autoantibody production, generation of inflammatory mediators and tissue damage. The goal of these studies is to understand disease mechanisms, identify therapeutic targets and stimulate development of therapeutics that can achieve improved outcomes for patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–224 of 224
Ultraviolet light induces HERV expression to activate RIG‐I signalling pathway in keratinocytes
Min, X., Zheng, M., Yu, Y., Wu, J., Kuang, Q., Hu, Z. Q., Ouyang, L., Lu, S., & Zhao, M. (2022) · Experimental Dermatology · doi:10.1111/exd.14568 · Cited by 33
Construction and Application of Polygenic Risk Scores in Autoimmune Diseases
Khunsriraksakul, C., Markus, H., Olsen, N. J., Carrel, L., Jiang, B., & Liu, D. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889296 · Cited by 33
Stearrett, N., Dawson, T., Rahnavard, A., Bachali, P., Bendall, M. L., Zeng, C., Caricchio, R., Pérez‐Losada, M., Grammer, A. C., Lipsky, P. E., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661437 · Cited by 31
APOL1 variant-expressing endothelial cells exhibit autophagic dysfunction and mitochondrial stress
Blazer, A., Qian, Y., Schlegel, M., Algasas, H., Buyon, J. P., Cadwell, K., Cammer, M., Heffron, S. P., Liang, F., Mehta‐Lee, S. S., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.769936 · Cited by 31
Hamilton, J. A., Wu, Q., Yang, P., Luo, B., Liu, S., Li, J., Mattheyses, A. L., Sanz, I., Chatham, W. W., Hsu, H., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800791 · Cited by 30
Genetic diagnosis of autoinflammatory disease patients using clinical exome sequencing
Batlle-Masó, L., Mensa‐Vilaró, A., Solís-Moruno, M., Marquès‐Bonet, T., Aróstegui, J. I., & Casals, F. (2020) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2020.103920 · Cited by 29
Hagberg, N., Lundtoft, C., & Rönnblom, L. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12894 · Cited by 28
Zhang, Y., Li, X., Gibson, A., Edberg, J. C., Kimberly, R. P., & Absher, D. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa131 · Cited by 28
Complement C4A Regulates Autoreactive B Cells in Murine Lupus
Simoni, L., Présumey, J., van der Poel, C. E., Castrillon, C. E., Chang, S. E., Utz, P. J., & Carroll, M. C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108330 · Cited by 28
Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus Erythematosus
Dominguez, D., Kamphuis, S., Beyene, J., Wither, J., Harley, J., Blanco, I., Vila-Inda, C., Brunner, H., Klein-Gitleman, M., Mccurdy, D., et al. (2020) · Journal of Rheumatology · doi:10.3899/jrheum.200002 · Cited by 27
Photosensitivity and cGAS-Dependent IFN-1 Activation in Patients with Lupus and TREX1 Deficiency
Berndt, N., Wolf, C., Fischer, K., Costa, E. C., Knuschke, P., Zimmermann, N., Schmidt, F., Merkel, M., Chara, O., Lee‐Kirsch, M. A., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.04.037 · Cited by 27
Functional genomics of autoimmune diseases
Suzuki, A., Guerrini, M. M., & Yamamoto, K. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216794 · Cited by 23
Integrating genetic and social factors to understand health disparities in lupus
Ramos, P. S. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000840 · Cited by 23
Sagy, I., Cohen, Y., Nahum, Y., Pokroy‐Shapira, E., Abu‐Shakra, M., & Molad, Y. (2022) · Lupus · doi:10.1177/09612033221084518 · Cited by 22
Berggren, O., Hagberg, N., Alexsson, A., Weber, G., Rönnblom, L., & Eloranta, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183946 · Cited by 21
Riella, C. V., McNulty, M. T., Ribas, G. T., Tattersfield, C. F., Perez-Gill, C., Eichinger, F. H., Kelly, J., Chun, J., Subramanian, B., Guizelini, D., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210150119 · Cited by 21
Felux, J., Erbacher, A., Breckler, M., Hervé, R., Lemeiter, D., Mannherz, H. G., Napirei, M., Rammensee, H., & Decker, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613597 · Cited by 20
Zhang, M., Chen, F., Zhang, D., Zhai, Z., & Hao, F. (2016) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2015.0289 · Cited by 19
Coit, P., Roopnarinesingh, X., Ortiz‐Fernández, L., McKinnon-Maksimowicz, K., Lewis, E. E., Merrill, J. T., McCune, W. J., Wren, J. D., & Sawalha, A. H. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2022-222656 · Cited by 19
Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus
Arora, S. K., & Yazdany, J. (2020) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2020.07.003 · Cited by 17
Extensive fragmentation and re-organization of transcription in Systemic Lupus Erythematosus
Ntasis, V. F., Panousis, N. I., Tektonidou, M. G., Dermitzakis, E. T., Boumpas, D. T., Bertsias, G. K., & Nikolaou, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-73654-4 · Cited by 14
Advances in lupus therapeutics: Achieving sustained control of the type I interferon pathway
Crow, M. K. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102291 · Cited by 12
Self-citationContributions of de novo variants to systemic lupus erythematosus
Almlöf, J. C., Nystedt, S., Mechtidou, A., Leonard, D., Eloranta, M., Grosso, G., Sjöwall, C., Bengtsson, A. A., Jönsen, A., Gunnarsson, I., et al. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0698-5 · Cited by 10
Marion, M. C., Ramos, P. S., Bachali, P., Labonte, A. C., Zimmerman, K. D., Ainsworth, H. C., Heuer, S. E., Robl, R. D., Catalina, M. D., Kelly, J. A., et al. (2021) · Genes · doi:10.3390/genes12121898 · Cited by 8
Cited by
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Systemic Lupus Erythematosus: A Review
Siegel, C. H., & Sammaritano, L. R. (2024) · JAMA · doi:10.1001/jama.2024.2315 · Cited by 535
Hoi, A., Igel, T., Mok, C. C., & Arnaud, L. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00398-2 · Cited by 399
Metadata
- Authors
- Crow, M. K.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2023-08
- Volume
- 82
- Issue
- 8
- Pages
- 999-1014
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W4320912323
- Cited by
- 398
- References
- 224
- FWCI
- 68.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.